BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $1.91 and last traded at $1.81, with a volume of 47472 shares traded. The stock had previously closed at $1.92.
BioRestorative Therapies Price Performance
The firm has a fifty day moving average price of $1.59 and a 200 day moving average price of $1.51. The firm has a market capitalization of $2.97 billion, a PE ratio of -0.03 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- Stock Splits, Do They Really Impact Investors?
- The Average 401k Balance by Age Explained
- ETF Screener: Uses and Step-by-Step Guide
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
